ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Heart failure

January 17, 2019
A succinct handy comment on a small series of left ventricular assist devices (LVAD) that is quite useful for a fast read on LVAD for surgeons and nonsurgeons.
December 26, 2018
A randomized controlled trial coauthored by the Editor-in-Chief of the host periodical on the risk management of multivessel diabetic coronopathy.
December 6, 2018
Gilles Dreyfus and colleagues share a decade of mitral reconstruction for degenerative posterior leaflet pathology in Harefield and Monaco (38 per year was the formidable average). The supplementary video is of particular educational value for the mitral surgeon and the cardiologist/TOE (TEE) specialist.
November 9, 2018
Interesting small randomized controlled trial that will definitely be widely discussed.
October 23, 2018
A post-market study (ELEVATE registry) of the fully magnetically levitated continuous flow HeartMate III left ventricular assist device (LVAD) found no pump thrombosis in 463 patients in Europe and Kazakhstan.
October 23, 2018
This video demonstrates a valve replacement surgery for a 55-year-old woman who presented with carcinoid heart disease caused by a primary ovarian carcinoid tumor.
October 12, 2018
The authors of this paper investigated the efficacy and safety of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) in 15 patients with hypertophic cardiomyopathy (HOCM). At six months, they found significant reductions in peak left ventricular outflow tract gradients and intraventricular septal thickness.
October 9, 2018
The authors demonstrate a successful pulmonary thromboendarterectomy, performed for a 37-year-old woman with chronic thromboembolic pulmonary hypertension.
October 2, 2018
Will await the full paper to test the titular preliminary assertion. 
September 25, 2018
This multicenter study evaluated the efficacy of medical therapy plus transcatheter valve repair (MitraClip) to medical therapy alone for heart failure accompanied by secondary moderate to severe mitral regurgitation. The device group experienced significantly fewer hospitalizations and lower mortality at 24 months follow-up. 

Pages